Others have investigated the utility of radiomics as a non-invasive approach to predict PD-L1 expression status.33 34 The current work is a significant advance over these prior studies, which were limited to a single institution, did not validate against independent cohorts, and used cohorts with many early-stage cancers included that are not candidates for ICI therapy. This evidence concerns the gene CD274 and cancer.